Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.
A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...
Purdue startup advances simple blood, urine tests to detect, monitor a myriad of early-stage cancers
WEST LAFAYETTE, Ind. – Researchers at Purdue-affiliated company who discovered a way to detect and monitor breast cancer using a simple blood test and bladder cancer using a urine test believe the ...
New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and screening.
Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the blood. The new technology could one day make it possible to ...
Using a single blood sample, multi-cancer early detection (MCED) tests screen for numerous types of cancers, including breast, ovarian, colorectal, pancreatic and prostate cancers. Trials are underway ...
TEXAS – A new wave of blood tests is changing how doctors detect cancer. These tests can find signs of cancer early, sometimes before symptoms appear, giving patients a better chance at successful ...
John (Eddie) La Marca receives funding from Cancer Council Victoria. He is affiliated with the Olivia Newton-John Cancer Research Institute and the Walter and Eliza Hall Institute of Medical Research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results